BMJ Evidence-Based Medicine

Papers
(The H4-Index of BMJ Evidence-Based Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture96
Proposed framework for unifying disease definitions in guideline development86
Challenges to delivering evidence-based management for long COVID79
Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST)69
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review67
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps50
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review42
How to best convey continuous outcomes in patient decision aids38
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study36
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?35
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study34
Global considerations for informed consent with shared decision-making in the digital age33
Making sustainable healthcare decisions: three turns towards sustainable guidelines32
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale28
Deceptive shifts in cancer stage distribution27
Deaths attributed to the use of medications purchased online26
Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis23
Leading with options or issues to support purposeful shared decision-making in clinical practice23
Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study23
Exploring the diverse definitions of ‘evidence’: a scoping review22
Genetic predisposition, modifiable lifestyles, and their joint effects on human lifespan: evidence from multiple cohort studies21
Assessing proposals to update established screening strategies21
Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions21
0.057372808456421